0HA3.L - Adverum Biotechnologies, Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 325.82%
S&P500 52-week change 34.08%
52-week high 31.7520
52-week low 30.0000
50-day moving average 30.8487
200-day moving average 30.9522

Share statistics

Avg vol (3-month) 31.58k
Avg vol (10-day) 33.48k
Shares outstanding 562.87M
Implied shares outstanding 6N/A
Float 878.45M
% held by insiders 13.70%
% held by institutions 163.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-3,956.03%

Management effectiveness

Return on assets (ttm)-26.07%
Return on equity (ttm)-66.11%

Income statement

Revenue (ttm)3.6M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -135.72M
Net income avi to common (ttm)-145.68M
Diluted EPS (ttm)-1.5780
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)164.28M
Total cash per share (mrq)1.63
Total debt (mrq)97.61M
Total debt/equity (mrq)61.88
Current ratio (mrq)3.63
Book value per share (mrq)1.57

Cash flow statement

Operating cash flow (ttm)-101.57M
Levered free cash flow (ttm)-66.78M